Goodbody Health Limited
(“Goodbody Health”, or the “Company”)

Progress Update: Phlebotomy Services

Goodbody Health (AQSE: GDBY) is pleased to announce that it has made significant progress with extending its phlebotomy services. The Company has signed 4 phlebotomy contracts with other testing suppliers who wish to use Goodbody Clinics as a phlebotomy partner. These initial partners are:

Rainbow Laboratories https://www.rainbowlabs.co.uk

Ted’s Health https://www.tedshealth.com

Omnos https://www.omnos.me

Vitall https://vitall.co.uk

This is a service the Company can offer due to the network of 90 phlebotomy clinics it has been able to build over the last two years both geographically and the deployment of extensive technical developments. The company is excited to integrate with additional providers in the space this year.

Furthermore, clinics now can now book blood tests for their own patients easily through the Goodbody portal giving greater access to testing and better trade margins. This reduces the dependency on Goodbody Clinic’s direct-to-consumer online model.

George Thomas, Chief Executive Officer, said: “We are very excited about all the opportunities available to us and our expanding network of phlebotomists to support customers with their health and wellbeing through offering more options for blood testing. As we have found from speaking to many providers and institutions in the space both in the finger-prick and venous draw markets, access to local clinics to take good quality blood draws has held back their access and growth, providing this service via our network gives us immediate growth and revenue opportunities. Marrying technology and healthcare services is a key part of strategy in 2023, and this is just the start”.

The Directors of the Company accept responsibility for the contents of this announcement.